[1]
“Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?”, Reumatismo, vol. 64, no. 5, pp. 321–325, Dec. 2012, doi: 10.4081/reumatismo.2012.321.